- Bile acid binding resins
- Mechanism- interrupt enterohepatic circulation of bile acids
- Not absorbed- so safe in children
- Decreases LDL
- GI side effects- constipation, abdominal pain
- Increases triglycerides
- Decreases absorption of other drugs
- Cholestyramine, colestipol and colesevelam
- Statins
- HMGCoA reductase inhibition- prevents mevalonate formation
- Inhibition of cellular cholesterol synthesis leads to enhanced LDL clearance from the plasma- decreased LDL
- Increases HDL
- Decreases plaque inflammation, decreases CRP
- Enhances endothelial function
- ADR- transaminase elevation, myositis
- Cholesterol absorption inhibitors- ezetimibe
- Decreases cholesterol and sitosterol absorption
- Mechanism- Interferes with Niemann-Pick C1-like 1 protein 1 (NPC1L1)
- Decreases LDL- used if statins alone are not enough to decrease LDL
- Useful in sitosterolemia also
- Fibrates
- Bezafibrate, fenofibrate and gemfibrozil
- Decrease triglycerides
- Can increase LDL
- Gemfibrozil can decrease statin elimination leading to myositis
- Mechanism- interacts with PPAR-a
- ADR- (EARSHOT)
- Erectile dysfunction
- Abdominal pain
- Rash
- Statin interaction
- Homocysteine elevation
- Oral anticoagulant interaction
- Transaminase elevation
- Nicotinic acid or niacin
- Decreases triglycerides and increases HDL
- Can slightly decrease LDL
- ADR-
- Hepatotoxicity
- Hyperglycemia
- Hyperuricemia
- Flushing
- Acanthosis nigricans
- Gastritis
- CETP inhibitor- torcetrapib
- CETP- cholesterol ester transfer protein
- Increases HDL
- ADR-
- Hepatotoxicity
- Hypertension
- Abdominal symptoms
- Removed from trials now
- Fish oils
- Contains PUFA
- Decreases triglycerides
- Antithrombotic effect
- Phytosterols
- Interferes with cholesterol absorption
- Probucol
- Antioxidant effect also
- Not used now as
- Reduces HDL
- Prolongs QT
Drugs that affect lipid metabolism
Comments (0)
- No comments yet.